Location of Repository

Gene Expression Changes in the Prefrontal Cortex, Anterior Cingulate Cortex and Nucleus Accumbens of Mood Disorders Subjects That Committed Suicide

By Adolfo Sequeira, Ling Morgan, David M. Walsh, Preston M. Cartagena, Prabhakara Choudary, Jun Li, Alan F. Schatzberg, Stanley J. Watson, Huda Akil, Richard M. Myers, Edward G. Jones, William E. Bunney and Marquis P. Vawter


Suicidal behaviors are frequent in mood disorders patients but only a subset of them ever complete suicide. Understanding predisposing factors for suicidal behaviors in high risk populations is of major importance for the prevention and treatment of suicidal behaviors. The objective of this project was to investigate gene expression changes associated with suicide in brains of mood disorder patients by microarrays (Affymetrix HG-U133 Plus2.0) in the dorsolateral prefrontal cortex (DLPFC: 6 Non-suicides, 15 suicides), the anterior cingulate cortex (ACC: 6NS, 9S) and the nucleus accumbens (NAcc: 8NS, 13S). ANCOVA was used to control for age, gender, pH and RNA degradation, with P≤0.01 and fold change±1.25 as criteria for significance. Pathway analysis revealed serotonergic signaling alterations in the DLPFC and glucocorticoid signaling alterations in the ACC and NAcc. The gene with the lowest p-value in the DLPFC was the 5-HT2A gene, previously associated both with suicide and mood disorders. In the ACC 6 metallothionein genes were down-regulated in suicide (MT1E, MT1F, MT1G, MT1H, MT1X, MT2A) and three were down-regulated in the NAcc (MT1F, MT1G, MT1H). Differential expression of selected genes was confirmed by qPCR, we confirmed the 5-HT2A alterations and the global down-regulation of members of the metallothionein subfamilies MT 1 and 2 in suicide completers. MTs 1 and 2 are neuro-protective following stress and glucocorticoid stimulations, suggesting that in suicide victims neuroprotective response to stress and cortisol may be diminished. Our results thus suggest that suicide-specific expression changes in mood disorders involve both glucocorticoids regulated metallothioneins and serotonergic signaling in different regions of the brain

Topics: Research Article
Publisher: Public Library of Science
OAI identifier: oai:pubmedcentral.nih.gov:3340369
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles



    1. (1974). A hundred cases of suicide: clinical aspects.
    2. (1992). A method for fixation of previously fresh-frozen human adult and fetal brains that preserves histological quality and immunoreactivity.
    3. (1997). A pair of adjacent glucocorticoid response elements regulate expression of two mouse metallothionein genes.
    4. (2003). Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element binding protein in postmortem brain of suicide subjects.
    5. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes.
    6. (1994). Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims.
    7. (2000). Affective disorders and suicide risk: a reexamination.
    8. (2004). affy–analysis of Affymetrix GeneChip data at the probe level.
    9. (1985). Agonal status affects the metabolic activity of nerve endings isolated from postmortem human brain.
    10. (2000). Altered 5-HT(2A) binding sites and second messenger inositol trisphosphate (IP(3)) levels in hippocampus but not in frontal cortex from depressed suicide victims.
    11. (2007). Altered expression of genes involved in ATP biosynthesis and GABAergic neurotransmission in the ventral prefrontal cortex of suicides with and without major depression. Mol Psychiatr.
    12. (2010). Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression. Mol Psychiatr.
    13. (2005). Association of 14–3-3 epsilon gene haplotype with completed suicide in Japanese.
    14. (1990). Biegon A
    15. (1993). Cerebral cortex Gsa protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder.
    16. (1984). Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene.
    17. (1995). Chemical modulation of metallothionein I and III mRNA in mouse brain.
    18. (1965). Correlations Between Behavioral Variables and Urinary 17-Hydroxycorticosteroids in Depressed Patients.
    19. (2009). CSF 5-HIAA and DST nonsuppression–orthogonal biologic risk factors for suicide in male mood disorder inpatients.
    20. (2004). Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain.
    21. (2009). Effect of olfactory bulbectomy on adenylyl cyclase activity in the limbic system.
    22. (1994). Effect of zinc, copper and glucocorticoids on metallothionein levels of cultured neurons and astrocytes from rat brain.
    23. (2009). Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse.
    24. (1969). Further evaluation of urinary 17-hydroxycorticosteroids in suicidal patients.
    25. (1999). G Protein-coupled cyclic AMP signaling in postmortem brain of subjects with mood disorders: effects of diagnosis, suicide, and treatment at the time of death.
    26. (2004). Gene expression profiling of depression and suicide in human prefrontal cortex.
    27. (2008). Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains.
    28. (2008). Gene expression profiling of post-mortem orbitofrontal cortex in violent suicide victims. The international journal of neuropsychopharmacology 11:
    29. (2006). Genome wide gene expression studies in mood disorders.
    30. Guze SB,Robins E(1970)Suicide and primaryaffective disorders.
    31. (2002). Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims.
    32. (2007). HTR2A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Current medicinal chemistry 14:
    33. (2009). Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: A meta-analysis.
    34. (2006). Implication of SSAT by gene expression and genetic variation in suicide and major depression.
    35. (1983). Increase serotonin-2 binding sites in frontal cortex of suicide victims.
    36. (1999). Induction of metallothionein by stress and its molecular mechanisms.
    37. (1996). Induction of metallothionein mRNA and protein in murine astrocyte cultures.
    38. (1996). Induction of metallothionein mRNA and protein in primary murine neuron cultures.
    39. (2008). Issues for DSM-V: suicidal behavior as a separate diagnosis on a separate axis.
    40. (2001). Levels of serotonin receptor 2A higher in suicide victims?
    41. (1998). Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia.
    42. (2009). Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
    43. (2009). Metallothionein I isoform mRNA expression in peripheral lymphocytes as a biomarker for occupational cadmium exposure.
    44. (1998). Metallothionein induction in response to restraint stress. Transcriptional control, adaptation to stress, and role of glucocorticoid.
    45. (2009). Metallothionein-I+II in neuroprotection.
    46. (2002). Metallothionein: the multipurpose protein. Cellular and molecular life sciences 59:
    47. (2007). Methodological considerations for gene expression profiling of human brain.
    48. (2006). Mitochondrialrelated gene expression changes are sensitive to agonal-pH state: implications for brain disorders. Mol Psychiatry 615.
    49. (2000). Molecular clock genes in man and lower animals: possible implications for circadian abnormalities in depression.
    50. (1997). Molinero A
    51. (2003). Neurobiology of suicidal behaviour.
    52. (2011). Neuron density and serotonin receptor binding in prefrontal cortex in suicide.
    53. (1968). Noradrenaline, 5-hydroxytryptamine, and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.
    54. (1965). Norepinephrine in depressive reactions. A review.
    55. (2009). Not fade away: the HPA axis and depression. Psychological Medicine.
    56. (2007). Patterns of gene expression in the limbic system of suicides with and without major depression.
    57. (1965). Possibility of a Biochemical Test for Suicidal Potential: An Analysis of Endocrine Findings Prior to Three Suicides.
    58. (1993). Pre-Postmortem influences on brain RNA.
    59. (1999). Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide.
    60. (2006). Projections of global mortality and burden of disease from
    61. (1990). Psychiatric findings in Wolfram syndrome homozygotes.
    62. (2008). Redefining the role of metallothionein within the injured brain: extracellular metallothioneins play an important role in the astrocyte-neuron response to injury.
    63. (1997). Reduced [3H]cyclic AMP binding in postmortem brain from subjects with bipolar affective disorder.
    64. (2002). Reducing Suicide: A National Imperative.
    65. (1997). Regulation of 5-HT receptors and the hypothalamic-pituitary-adrenal axis. Implications for the neurobiology of suicide.
    66. (1994). Regulation of metallothionein concentrations in rat brain: effect of glucocorticoids, zinc, copper, and endotoxin. The American journal of physiology 266:
    67. (1996). Reliability of DSM-III-R diagnosis by psychological autopsy: a comparison with clinician antemortem diagnosis.
    68. (1988). Risk factors for adolescent suicide. A comparison of adolescent suicide victims with suicidal inpatients.
    69. (2001). Roles of the metallothionein family of proteins in the central nervous system.
    70. (1997). Serotonin receptors in suicide victims with major depression.
    71. (1959). Some clinical considerations in the prevention of suicide based on a study of 134 successful suicides.
    72. (2000). Suicide and bipolar disorder.
    73. (1994). Suicide and mental disorders: a case-control study of young men.
    74. (2008). Suicide and suicidal behavior.
    75. (2007). Suicide candidate genes associated with bipolar disorder and schizophrenia: an exploratory gene expression profiling analysis of post-mortem prefrontal cortex.
    76. (2007). Suicide in children and adolescents.
    77. (1990). Suicide, in Manic-Depressive Illness. In: Suicide, in Manic-Depressive Illness.
    78. (2004). Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions.
    79. (2000). The biology of impulsivity and suicidality. The Psychiatric clinics of
    80. (2008). Transcriptome alterations in the prefrontal cortex of subjects with schizophrenia who committed suicide.
    81. (2006). Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment.
    82. (1998). Weizman A
    83. (2003). Wolfram syndrome and suicide: Evidence for a role of WFS1 in suicidal and impulsive behavior.
    84. (2005). Wolframin mutations and hospitalization for psychiatric illness.
    85. (2000). World Health Report

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.